Cargando…
Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study
OBJECTIVE: EBUS-TBNA cytological sampling is routinely performed for pathological diagnosis, mediastinal staging, and molecular testing in lung cancer patients. EBUS-TBNA samples are not formally accepted for testing programmed death-ligand 1 (PD-L1) expression. The objective of the study was to com...
Autores principales: | Guarize, Juliana, Rocco, Elena Guerini, de Marinis, Filippo, Sedda, Giulia, Bertolaccini, Luca, Donghi, Stefano Maria, Casiraghi, Monica, Tonno, Clementina Di, Barberis, Massimo, Spaggiari, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Pneumologia e Tisiologia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332653/ https://www.ncbi.nlm.nih.gov/pubmed/34259745 http://dx.doi.org/10.36416/1806-3756/e20200584 |
Ejemplares similares
-
Diagnostic Performance and Cell Count of EBUS–TBNA Needle Gauges: A Prospective Trial
por: Guarize, Juliana, et al.
Publicado: (2023) -
EBUS-TBNA in PET-positive lymphadenopathies in treated cancer patients
por: Guarize, Juliana, et al.
Publicado: (2017) -
In EBUS Signo Vinces: New Indications in Thoracic Oncology for Mediastinal Lymph Node Staging Using Endobronchial Ultrasound
por: Guarize, Juliana, et al.
Publicado: (2022) -
Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review
por: Bertolaccini, Luca, et al.
Publicado: (2021) -
Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer
por: Bertolaccini, Luca, et al.
Publicado: (2022)